kennzo

QGEN (Qiagen N.V) - Bullish quarterly outlook

Long
kennzo Updated   
NYSE:QGEN   Qiagen N.V.
Qiagen N.V

Qiagen NV produces biomedical and genetic products, products for separating and purifying nucleic acids for gene-based drug screening, nucleic acid-based clinical diagnostics, genetic vaccination and gene therapy.

Analysis/Commentary
Strong EPS and Sales Growth Y-on-Y

Based on the study of the previous quarterly earnings reports and subsequent price moves:
- Current quarter has started well, however, we have an opportunity for pull-back now and entry
- Looking for a price closer to the LOW point, confirmed by Slo Stochastic
- Expectation for the price to then move to MID or HIGH point
- Trailing stop-loss on price above MID point

GOOD LUCK.
DO YOUR OWN RESEARCH!
Comment:
TRADE UPDATE: Unsuccessful
Further analysis to follow for learning
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.